About the Authors

Catherine Menten-Dedoyart

Contributed equally to this work with: Catherine Menten-Dedoyart, Maria Elisa Serrano Navacerrada

Affiliation GIGA-Neurosciences, University of Liège, Liège, Belgium

Maria Elisa Serrano Navacerrada

Contributed equally to this work with: Catherine Menten-Dedoyart, Maria Elisa Serrano Navacerrada

Affiliation Cyclotron Research Center, University of Liège, Liège, Belgium

Odile Bartholome

Affiliation GIGA-Neurosciences, University of Liège, Liège, Belgium

Judit Sánchez Gil

Affiliation GIGA-Neurosciences, University of Liège, Liège, Belgium

Virginie Neirinckx

Affiliation GIGA-Neurosciences, University of Liège, Liège, Belgium

Sabine Wislet

Affiliation GIGA-Neurosciences, University of Liège, Liège, Belgium

Guillaume Becker

Affiliation Cyclotron Research Center, University of Liège, Liège, Belgium

Alain Plenevaux

Affiliation Cyclotron Research Center, University of Liège, Liège, Belgium

Priscilla Van den Ackerveken

‡ These authors also contributed equally to this work.

Affiliation GIGA-Neurosciences, University of Liège, Liège, Belgium

Bernard Rogister

Bernard.Rogister@ulg.ac.be

‡ These authors also contributed equally to this work.

Affiliations GIGA-Neurosciences, University of Liège, Liège, Belgium, Neurology Department, CHU, Academic Hospital, University of Liège, Liège, Belgium

Competing Interests

The funders UCB Pharma had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: BR AP. Formal analysis: CMD MESN VN OB JSG PVdA GB. Funding acquisition: BR AP. Investigation: CMD MESN VN OB JSG PVdA. Methodology: BR. Project administration: BR AP. Resources: BR AP. Supervision: BR AP. Visualization: CMD MESN VN OB JSG PVdA BR GB SW. Writing – original draft: CMD PVdA BR. Writing – review & editing: PVdA BR.